JP
Jalaj Paliwal
About Jalaj Paliwal
Data last updated:
Jalaj Paliwal is a Director at Taurlib Pharma Private Limited (since 2024) and Designated Partner at Taurlib Pharmaceuticals Llp (since 2019). The companies operate in Business Services.
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Taurlib Pharma Private Limited U46497DL2024PTC430460 | Director | 28 Apr 2024 | 2024 | Active | |
| Taurlib Pharmaceuticals Llp AAO-3942 | Designated Partner | 27 Feb 2019 | 2019 | Active |
Board colleagues of Jalaj Paliwal
| Name | DIN | Company | Designation |
|---|---|---|---|
| Vaibhav Singh | 08376632 | Taurlib Pharma Private Limited , Taurlib Pharmaceuticals Llp | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Jalaj Paliwal
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Jalaj Paliwal
Jalaj Paliwal currently holds 2 directorships: Taurlib Pharma Private Limited (Director, since 28 Apr 2024); Taurlib Pharmaceuticals Llp (Designated Partner, since 27 Feb 2019).
Jalaj Paliwal was first appointed on 27 Feb 2019 as Designated Partner at Taurlib Pharmaceuticals Llp. The most recent appointment on record is 28 Apr 2024 at Taurlib Pharma Private Limited.
The current boards of Jalaj Paliwal's companies include Vaibhav Singh (Taurlib Pharma Private Limited).